Accunea

London, United Kingdom Founded: 2017 • Age: 9 yrs
Monitoring devices for kidney function are developed by Accunea.

About Accunea

Accunea is a company based in London (United Kingdom) founded in 2017.. Accunea has raised $258.15 thousand across 2 funding rounds. The company has 1 employees as of January 31, 2022. Accunea offers products and services including Accunea Monitoring System and AI Trend Analysis Tool. Accunea operates in a competitive market with competitors including MediBeacon, Physidia, FAST BioMedical, Utopic Tech and Prantae Solutions, among others.

  • Headquarter London, United Kingdom
  • Employees 1 as on 31 Jan, 2022
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Accunea Ltd.
  • Date of Incorporation 09 Mar, 2017
  • Jurisdiction KIDDERMINSTER, WORCESTERSHIRE
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $258.15 K (USD)

    in 2 rounds

  • Latest Funding Round
    $121.87 K (USD), Seed

    Aug 11, 2022

  • Investors
  • Employee Count
    1

    as on Jan 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Accunea

Accunea offers a comprehensive portfolio of products and services, including Accunea Monitoring System and AI Trend Analysis Tool. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Monitors biomarkers for kidney transplant viability and patient recovery.

Provides AI insights on organ function trends during transplants.

Funding Insights of Accunea

Accunea has successfully raised a total of $258.15K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $121.87 thousand completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $121,873
  • First Round

    (05 Jan 2021)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2022 Amount Seed - Accunea Valuation

investors

Jan, 2021 Amount Seed - Accunea Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Accunea

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Accunea

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Accunea Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Accunea

Accunea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediBeacon, Physidia, FAST BioMedical, Utopic Tech and Prantae Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Non-invasive optical monitoring of kidney function is developed.
domain founded_year HQ Location
Manufacturer of a hemodialysis monitoring device
domain founded_year HQ Location
Develops fluorescent in-vivo markers for measuring plasma volume and mGFR.
domain founded_year HQ Location
Medical device for kidney diagnosis and management is developed.
domain founded_year HQ Location
Medical imaging and devices for pregnancy monitoring are developed.
domain founded_year HQ Location
Develops innovative devices for bladder monitoring in urology.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Accunea

Frequently Asked Questions about Accunea

When was Accunea founded?

Accunea was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is Accunea located?

Accunea is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Who is the current CEO of Accunea?

Nick Housby is the current CEO of Accunea.

Is Accunea a funded company?

Accunea is a funded company, having raised a total of $258.15K across 2 funding rounds to date. The company's 1st funding round was a Seed of $136.28K, raised on Jan 05, 2021.

How many employees does Accunea have?

As of Jan 31, 2022, the latest employee count at Accunea is 1.

What does Accunea do?

Accunea was founded in 2017 in London, United Kingdom, within the medical device sector. A microsensor array is developed to enable continuous real-time monitoring of kidney function biomarkers. Information on transplant organ performance is provided at the point of care. An AI system is utilized for population-based comparisons and early alerts. Operations focus on innovative assays for established functional markers in renal health.

Who are the top competitors of Accunea?

Accunea's top competitors include MediBeacon, Physidia and Utopic Tech.

What products or services does Accunea offer?

Accunea offers Accunea Monitoring System and AI Trend Analysis Tool.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available